Ocuphire Pharma Inc.
1.17
-0.16 (-12.03%)
At close: Oct 23, 2024, 8:00 PM

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05
Cash & Equivalents 50.50M 42.63M 24.53M 16.40M 1.54M 8.74M 8.90M 11.58M 10.20M 9.83M 18.69M 13.49M 9.86M 12.34M 7.30M 369.13K 7.36M 4.03M n/a
Short-Term Investments 15.00K 49.00K 219.00K n/a 3.00M 5.98M 17.93M 8.74M 13.24M 22.87M 100.00K 100.00K 1.95M 2.45M 175.00K 3.00M n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a 30.79K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets n/a -636.00K -10.00K -14.00K n/a 30.79K 30.78K 30.78K n/a 103.78K 261.30K 1.14M 1.53M 544.14K 2.20M 92.21K 102.95K 149.99K n/a
Receivables 2.33M 4.85M n/a n/a 125.00K n/a n/a n/a n/a n/a n/a n/a 18.68K 28.02K n/a n/a n/a n/a n/a
Inventory n/a 1.00 n/a n/a 95.00K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets 1.10M 1.45M 1.31M 26.00K 5.00K 1.17M 1.30M 608.52K 1.22M 730.99K 507.17K 188.81K 333.17K 852.16K 320.94K 366.76K 717.21K 483.19K n/a
Total Current Assets 53.95M 48.99M 26.07M 17.67M 1.76M 15.90M 28.14M 20.92M 24.66M 33.43M 19.30M 13.78M 12.16M 15.67M 7.79M 3.74M 8.08M 4.52M n/a
Property-Plant & Equipment n/a 6.00K 10.00K 14.00K 22.00K 112.47K 121.46K 88.65K 112.90K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 286.13K 303.94K 321.97K n/a
Total Long-Term Assets n/a 6.00K 10.00K 14.00K 22.00K 143.26K 152.24K 119.43K 143.69K 103.78K 261.30K 1.14M 1.53M 544.14K 2.20M 378.34K 406.89K 471.96K n/a
Total Assets 53.95M 48.99M 26.08M 17.68M 1.78M 16.04M 28.29M 21.04M 24.81M 33.53M 19.56M 14.92M 13.69M 16.22M 9.99M 4.11M 8.48M 4.99M n/a
Account Payables 2.15M 1.07M 1.58M 1.21M 342.00K 547.52K n/a n/a 774.54K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Deferred Revenue n/a n/a n/a n/a 621.00K -1.34M n/a n/a n/a n/a n/a n/a n/a 900.00K 975.00K 1.05M 1.13M 1.20M n/a
Short-Term Debt n/a n/a 538.00K n/a 5.67M 1.34M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities 1.89M 1.68M 1.73M 1.97M 2.71M 2.61M 3.23M 1.88M 1.89M n/a n/a n/a n/a n/a n/a -691.11K -518.17K -624.64K n/a
Total Current Liabilities 4.04M 2.75M 3.85M 3.19M 9.34M 3.15M 3.23M 1.88M 2.66M n/a n/a n/a n/a 900.00K 975.00K 358.89K 606.83K 575.36K n/a
Long-Term Debt n/a n/a n/a n/a 63.60K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities n/a 433.00K n/a 27.96M 41.72K 2.33M 7.91M 1.65M 2.84M n/a n/a n/a n/a 4.92M 914.40K 1.05M 1.13M 1.20M n/a
Total Long-Term Liabilities n/a 1.07M n/a 27.96M 105.32K 2.33M 8.29M 2.10M 3.37M n/a n/a n/a n/a 4.92M 914.40K 1.05M 1.13M 1.20M n/a
Total Liabilities 4.04M 2.75M 3.85M 31.15M 9.34M 5.48M 11.52M 3.99M 6.03M n/a n/a n/a n/a 5.82M 1.89M 1.41M 1.73M 1.78M n/a
Total Debt n/a n/a 538.00K n/a 5.67M 1.34M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock 2.00K 2.00K 2.00K 1K 402.00 3.75K 3.17K 23.74K 19.74K 17.84K 14.67K 11.94K 9.54K 8.42K 7.19K 5.60K 5.53K 5.03K n/a
Retained Earnings -81.47M -71.48M -89.37M -32.67M -8.05M -154.69M -140.32M -115.02M -105.72M -91.33M -72.81M -63.31M -57.08M -45.74M -36.29M -29.91M -24.99M -20.69M n/a
Comprehensive Income -0.00 n/a n/a n/a 2.08K -17.84K -56.89K -6.12K -18.04K -33.65K n/a n/a n/a -2.34K n/a -550.48K n/a n/a n/a
Shareholders Equity 49.91M 46.24M 22.22M -13.47M -7.56M 10.56M 16.77M 17.06M 18.78M 26.58M 12.63M 9.53M 10.71M 10.40M 8.10M 2.71M 6.75M 3.21M n/a
Total Investments 15.00K 49.00K 219.00K n/a 3.00M 5.98M 17.93M 8.74M 13.27M 22.87M 100.00K 100.00K 1.95M 2.45M 175.00K 3.00M n/a n/a n/a